Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.25 USD | -3.24% |
|
-7.50% | -30.66% |
06-04 | GoHealth Names Katherine O'Halloran Interim CFO | MT |
06-04 | GoHealth, Inc. Announces Resignation of Jason Schulz as Treasurer | CI |
Valuation
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Capitalization 1 | 1,150 | 435 | 92.91 | 127.5 | 92.01 | - |
Enterprise Value (EV) 1 | 1,406 | 1,021 | 586.5 | 127.5 | 92.01 | 92.01 |
P/E ratio | -62.1 x | -2.12 x | -0.59 x | -1.86 x | -1.74 x | -2.1 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.31 x | 0.41 x | 0.15 x | 0.17 x | 0.12 x | 0.12 x |
EV / Revenue | 1.31 x | 0.41 x | 0.15 x | 0.17 x | 0.12 x | 0.12 x |
EV / EBITDA | 4.24 x | 12.9 x | -0.72 x | 1.7 x | 1.18 x | 0.98 x |
EV / FCF | -8.93 x | -1.36 x | 1.96 x | - | 1.4 x | 0.96 x |
FCF Yield | -11.2% | -73.3% | 51% | - | 71.7% | 104% |
Price to Book | 3.02 x | 1.14 x | 0.35 x | - | - | - |
Nbr of stocks (in thousands) | 5,612 | 7,652 | 8,890 | 9,554 | 9,947 | - |
Reference price 2 | 204.9 | 56.85 | 10.45 | 13.34 | 9.250 | 9.250 |
Announcement Date | 3/8/21 | 3/15/22 | 3/16/23 | 3/14/24 | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net sales 1 | 877.4 | 1,062 | 631.7 | 734.7 | 750.6 | 787.3 |
EBITDA 1 | 271 | 33.82 | -129.8 | 75.09 | 78.21 | 93.43 |
EBIT 1 | -64.55 | -489.4 | -318.7 | -81.68 | -49.18 | -36.11 |
Operating Margin | -7.36% | -46.07% | -50.45% | -11.12% | -6.55% | -4.59% |
Earnings before Tax (EBT) 1 | -97.16 | -534.2 | -375.6 | -151.1 | -117.3 | -98.53 |
Net income 1 | -44.27 | -189.4 | -148.7 | -63.26 | -51.26 | -43.29 |
Net margin | -5.05% | -17.82% | -23.54% | -8.61% | -6.83% | -5.5% |
EPS 2 | -3.300 | -26.85 | -17.72 | -7.190 | -5.315 | -4.408 |
Free Cash Flow 1 | -128.7 | -318.8 | 47.39 | - | 65.92 | 95.42 |
FCF margin | -14.67% | -30.01% | 7.5% | - | 8.78% | 12.12% |
FCF Conversion (EBITDA) | - | - | - | - | 84.28% | 102.12% |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 3/8/21 | 3/15/22 | 3/16/23 | 3/14/24 | - | - |
Income Statement Evolution (Quarterly data)
Fiscal Period: December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales 1 | 449.6 | 270.6 | 158.7 | 133.1 | 69.38 | 183.2 | 142.8 | 132 | 276.7 | 185.6 | 141.8 | 133.1 | 290 | 195 | 150 |
EBITDA 1 | 1.499 | 11.07 | -31.74 | -14.33 | -94.78 | 28.78 | 0.788 | -11.48 | 57 | 26.89 | -8.661 | -7.822 | 67.79 | - | - |
EBIT 1 | -423.3 | -25.31 | -76.05 | -59.14 | -133.2 | -5.749 | -53.02 | -37.98 | 15.06 | -4.032 | -41.26 | -39.95 | 35.94 | 6.55 | -34.6 |
Operating Margin | -94.15% | -9.35% | -47.93% | -44.45% | -191.97% | -3.14% | -37.13% | -28.76% | 5.44% | -2.17% | -29.1% | -30.01% | 12.39% | 3.36% | -23.07% |
Earnings before Tax (EBT) 1 | -432.2 | -36.77 | -113.8 | -74.65 | -150.4 | -22.59 | -70.3 | -56.31 | -1.915 | -21.42 | -58.56 | -56.78 | 19.51 | -8.45 | -49.6 |
Net income 1 | -155.1 | -13.48 | -43.82 | -30 | -61.4 | -9.179 | -28.94 | -23.91 | -1.226 | -9.216 | -25.32 | -24.54 | 8.03 | -3.759 | -21.04 |
Net margin | -34.5% | -4.98% | -27.62% | -22.55% | -88.5% | -5.01% | -20.27% | -18.11% | -0.44% | -4.97% | -17.86% | -18.43% | 2.77% | -1.93% | -14.03% |
EPS 2 | -20.25 | -1.800 | -5.250 | -3.450 | -7.000 | -1.120 | -3.270 | -2.610 | -0.1500 | -1.040 | -2.608 | -2.518 | 0.5950 | -0.4900 | -2.290 |
Dividend per Share | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Announcement Date | 3/15/22 | 5/10/22 | 8/15/22 | 11/10/22 | 3/16/23 | 5/8/23 | 8/10/23 | 11/9/23 | 3/14/24 | 5/9/24 | - | - | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|---|---|
Net Debt | 256 | 586 | 494 | - | - | - |
Net Cash position | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | 0.9458 x | 17.33 x | -3.804 x | - | - | - |
Free Cash Flow 1 | -129 | -319 | 47.4 | - | 65.9 | 95.4 |
ROE (net income / shareholders' equity) | -7.15% | -51.6% | -47.8% | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - |
Assets 1 | - | - | - | - | - | - |
Book Value Per Share | 67.80 | 50.00 | 30.00 | - | - | - |
Cash Flow per Share | - | -42.30 | 7.210 | - | - | - |
Capex 1 | 14.5 | - | 13.5 | 13.7 | 16.6 | 16 |
Capex / Sales | 1.66% | - | 2.14% | 1.87% | 2.21% | 2.03% |
Announcement Date | 3/8/21 | 3/15/22 | 3/16/23 | 3/14/24 | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-30.66% | 92.01M | |
+12.73% | 55.39B | |
+9.31% | 26.95B | |
+27.38% | 25.84B | |
+9.92% | 7.73B | |
+33.87% | 6.86B | |
+4.47% | 4.48B | |
0.00% | 3.68B | |
+13.33% | 2.43B | |
+45.55% | 2.31B |
- Stock Market
- Equities
- GOCO Stock
- Financials GoHealth, Inc.